Fusco A - Search Results

1

MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle.

Visone R, Russo L, Pallante P, De Martino I, Ferraro A, Leone V, Borbone E, Petrocca F, Alder H, Croce CM, Fusco A. Visone R, et al. Among authors: fusco a. Endocr Relat Cancer. 2007 Sep;14(3):791-8. doi: 10.1677/ERC-07-0129. Endocr Relat Cancer. 2007. PMID: 17914108

2

Increased expression of the negative growth factor, galactoside-binding protein, gene in transformed thyroid cells and in human thyroid carcinomas.

Chiariotti L, Berlingieri MT, De Rosa P, Battaglia C, Berger N, Bruni CB, Fusco A. Chiariotti L, et al. Among authors: fusco a. Oncogene. 1992 Dec;7(12):2507-11. Oncogene. 1992. PMID: 1461653

3

PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas.

Grieco M, Santoro M, Berlingieri MT, Melillo RM, Donghi R, Bongarzone I, Pierotti MA, Della Porta G, Fusco A, Vecchio G. Grieco M, et al. Among authors: fusco a. Cell. 1990 Feb 23;60(4):557-63. doi: 10.1016/0092-8674(90)90659-3. Cell. 1990. PMID: 2406025

4

High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma.

Bongarzone I, Pierotti MA, Monzini N, Mondellini P, Manenti G, Donghi R, Pilotti S, Grieco M, Santoro M, Fusco A, et al. Bongarzone I, et al. Among authors: fusco a. Oncogene. 1989 Dec;4(12):1457-62. Oncogene. 1989. PMID: 2594368

5

Molecular defects in thyroid carcinomas: role of the RET oncogene in thyroid neoplastic transformation.

Santoro M, Grieco M, Melillo RM, Fusco A, Vecchio G. Santoro M, et al. Among authors: fusco a. Eur J Endocrinol. 1995 Nov;133(5):513-22. doi: 10.1530/eje.0.1330513. Eur J Endocrinol. 1995. PMID: 7581978 Review.

6

Expression of galectin-1 in normal human thyroid gland and in differentiated and poorly differentiated thyroid tumors.

Chiariotti L, Berlingieri MT, Battaglia C, Benvenuto G, Martelli ML, Salvatore P, Chiappetta G, Bruni CB, Fusco A. Chiariotti L, et al. Among authors: fusco a. Int J Cancer. 1995 Jun 22;64(3):171-5. doi: 10.1002/ijc.2910640305. Int J Cancer. 1995. PMID: 7622305

7

Cloning of the rat tissue inhibitor of metalloproteinases type 2 (TIMP-2) gene: analysis of its expression in normal and transformed thyroid cells.

Santoro M, Battaglia C, Zhang L, Carlomagno F, Martelli ML, Salvatore D, Fusco A. Santoro M, et al. Among authors: fusco a. Exp Cell Res. 1994 Aug;213(2):398-403. doi: 10.1006/excr.1994.1215. Exp Cell Res. 1994. PMID: 8050496

8

Frequent activation of ret protooncogene by fusion with a new activating gene in papillary thyroid carcinomas.

Bongarzone I, Butti MG, Coronelli S, Borrello MG, Santoro M, Mondellini P, Pilotti S, Fusco A, Della Porta G, Pierotti MA. Bongarzone I, et al. Among authors: fusco a. Cancer Res. 1994 Jun 1;54(11):2979-85. Cancer Res. 1994. PMID: 8187085

9

Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice.

Santoro M, Chiappetta G, Cerrato A, Salvatore D, Zhang L, Manzo G, Picone A, Portella G, Santelli G, Vecchio G, Fusco A. Santoro M, et al. Among authors: fusco a. Oncogene. 1996 Apr 18;12(8):1821-6. Oncogene. 1996. PMID: 8622903

10

Status and expression of the p16INK4 gene in human thyroid tumors and thyroid-tumor cell lines.

Calabrò V, Strazzullo M, La Mantia G, Fedele M, Paulin C, Fusco A, Lania L. Calabrò V, et al. Among authors: fusco a. Int J Cancer. 1996 Jul 3;67(1):29-34. doi: 10.1002/(SICI)1097-0215(19960703)67:1<29::AID-IJC7>3.0.CO;2-1. Int J Cancer. 1996. PMID: 8690521

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,154 results

Search Page

Filters